by Peter Ciszewski | Aug 26, 2019
“Physicians of all types need to be involved with (clinical trial research) because the biotechnology is advancing so rapidly right now,” said Neal Weinreb, MD, a leading genetics and lysosomal storage disease researcher located in Coral Springs, Florida. Dr....
by Peter Ciszewski | Aug 20, 2019
Spark Therapeutics is developing a gene therapy to treat one of the most devastating genetic disease known – Huntington’s disease. A disease that robs people of their motor skills and psychological stability in the prime of their life. Recently, we talked with...
by Peter Ciszewski | Aug 19, 2019
Prof. Arndt Rolfs, MD, Chief Executive Officer at Centogene discuses the challenges of diagnostic testing and how Centogene is overcoming some of these challenges. There is no current gold standard for genetic testing and companies such as Centogene are...
by Peter Ciszewski | Aug 16, 2019
Hideki Garren, MD, PhD, global head of neuroimmunology at Roche, discusses neuromyelitis optica spectrum disease (NMOSD), a rare autoimmune disease that affects the central nervous system that often leads to damaged optic nerves and spinal cord. Blindness,...
by Peter Ciszewski | Aug 14, 2019
Heather A. Lau, MD, Assistant Professor, Department of Neurology; Associate Director, Division of Neurogenetics; Director, Lysosomal Storage Disease Program at NYU Langone Health, discusses some of the approved and emerging therapies for mucopolysaccharidoses...
